Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues

Use of a Monte Carlo analysis within a physiologically based pharmacokinetic model to predict doxycycline residue withdrawal time in edible tissues in swine

Food Additives & Contaminants Part A ◽

10.1080/19440049.2011.624126 ◽

2012 ◽

Vol 29 (1) ◽

pp. 73-84 ◽

Cited By ~ 30

Author(s):

F. Yang ◽

H.W. Liu ◽

M. Li ◽

H.Z. Ding ◽

X.H. Huang ◽

...

Keyword(s):

Monte Carlo ◽

Pharmacokinetic Model ◽

Monte Carlo Analysis ◽

Withdrawal Time ◽

Physiologically Based ◽

Edible Tissues

A physiologically based pharmacokinetic model for the prediction of the depletion of methyl-3-quinoxaline-2-carboxylic acid, the marker residue of olaquindox, in the edible tissues of pigs

Journal of Veterinary Pharmacology and Therapeutics ◽

10.1111/jvp.12053 ◽

2013 ◽

Vol 37 (1) ◽

pp. 66-82 ◽

Cited By ~ 17

Author(s):

B. Yang ◽

L. L. Huang ◽

K. Fang ◽

Y. L. Wang ◽

D. P. Peng ◽

...

Keyword(s):

Carboxylic Acid ◽

Pharmacokinetic Model ◽

Physiologically Based ◽

Edible Tissues

Pharmacokinetic model of circulating covalent aggregates of insulin

Diabetes ◽

10.2337/diabetes.37.8.1059 ◽

1988 ◽

Vol 37 (8) ◽

pp. 1059-1063 ◽

Cited By ~ 7

Author(s):

M. Maislos ◽

M. Bialer ◽

P. M. Mead ◽

D. C. Robbins

Keyword(s):

Pharmacokinetic Model

Physiologically based pharmacokinetic model development for trazodone: application to paediatric dose projection

10.26226/morressier.5971be87d462b80290b534f2 ◽

2017 ◽

Author(s):

F. Calisti

Keyword(s):

Pharmacokinetic Model ◽

Model Development ◽

Physiologically Based ◽

Paediatric Dose

Faculty Opinions recommendation of Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.5366956.5318054 ◽

2010 ◽

Author(s):

Johan Coetzee

Keyword(s):

Pharmacokinetic Model

Faculty Opinions recommendation of Development of an Optimized Pharmacokinetic Model of Dexmedetomidine Using Target-controlled Infusion in Healthy Volunteers.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725550632.793511383 ◽

2015 ◽

Author(s):

Harald Ihmsen

Keyword(s):

Healthy Volunteers ◽

Pharmacokinetic Model ◽

Target Controlled Infusion

Population Pharmacokinetic Model for Intravenous ASN100 in Healthy Subjects

Open Forum Infectious Diseases ◽

10.1093/ofid/ofx163.1379 ◽

2017 ◽

Vol 4 (suppl_1) ◽

pp. S529-S529

Author(s):

Scott A Van Wart ◽

Christopher Stevens ◽

Zoltan Magyarics ◽

Steven A Luperchio ◽

Paul G Ambrose

Keyword(s):

Healthy Subjects ◽

Population Pharmacokinetic Model ◽

Pharmacokinetic Model ◽

Population Pharmacokinetic

A semi‐mechanistic pharmacokinetic model for depot medroxyprogesterone acetate and drug‐drug interactions with antiretroviral and antituberculosis treatment.

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.2324 ◽

2021 ◽

Author(s):

Jose Francis ◽

Rosie Mngqibisa ◽

Helen McIlleron ◽

Michelle A Kendall ◽

Xingye Wu ◽

...

Keyword(s):

Drug Interactions ◽

Medroxyprogesterone Acetate ◽

Pharmacokinetic Model ◽

Depot Medroxyprogesterone Acetate ◽

Antituberculosis Treatment

Risk Assessment of Perfluorooctane Sulfonate (PFOS) using Dynamic Age Dependent Physiologically based Pharmacokinetic Model (PBPK) across human lifetime

Environmental Research ◽

10.1016/j.envres.2021.111287 ◽

2021 ◽

pp. 111287

Author(s):

Deepika Deepika ◽

Raju Prasad Sharma ◽

Marta Schuhmacher ◽

Vikas Kumar

Keyword(s):

Risk Assessment ◽

Pharmacokinetic Model ◽

Perfluorooctane Sulfonate ◽

Physiologically Based ◽

Age Dependent

Population pharmacokinetic model with time‐varying clearance for lorlatinib using pooled data from patients with non‐small cell lung cancer and healthy participants

CPT Pharmacometrics & Systems Pharmacology ◽

10.1002/psp4.12585 ◽

2021 ◽

Vol 10 (2) ◽

pp. 148-160

Author(s):

Joseph Chen ◽

Brett Houk ◽

Yazdi K. Pithavala ◽

Ana Ruiz‐Garcia

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Population Pharmacokinetic Model ◽

Pharmacokinetic Model ◽

Small Cell ◽

Population Pharmacokinetic ◽

Time Varying ◽

Small Cell Lung ◽

Pooled Data ◽

Healthy Participants